Stay updated on Alirocumab vs Statin for Neoatherosclerosis Clinical Trial
Sign up to get notified when there's something new on the Alirocumab vs Statin for Neoatherosclerosis Clinical Trial page.
Latest updates to the Alirocumab vs Statin for Neoatherosclerosis Clinical Trial page
- Check3 days agoChange DetectedThe new version adds the last known status and responsible party (Hiromasa Otake, Kobe University) with the date 2018-05, and notes the recruitment status in the study record history.SummaryDifference1.0%
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedRevision history shows a new revision: v3.3.3 was added. The HHS Vulnerability Disclosure link and the v3.3.2 revision note were removed from the footer.SummaryDifference0.2%
- Check24 days agoNo Change Detected
- Check39 days agoChange DetectedNew revision v3.3.2 was added to the record history, and the previous revision v3.3.1 was removed.SummaryDifference0.1%
- Check46 days agoChange DetectedThe page history shows an addition of revision v3.3.1 and a deletion of v3.2.0, which appear to be administrative/versioning updates rather than substantive content changes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check53 days agoChange DetectedDeleted the global notice about government funding and operating status; the page now presents without that notice. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%
- Check68 days agoChange DetectedThe Record History page shows two versions with their submission dates; no substantive study data has changed.SummaryDifference0.1%
Stay in the know with updates to Alirocumab vs Statin for Neoatherosclerosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Alirocumab vs Statin for Neoatherosclerosis Clinical Trial page.